Records containing: Hepatic Encephalopathy
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-10-28A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis
-
CLINICAL_TRIALS study results posted · 2026-09-10A Randomized Open-label Trial of Deprescribing Proton Pump Inhibitors to Reduce the Risk of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Creation
-
CLINICAL_TRIALS study record update · 2026-04-14Microbiota Transplant Therapy to Prevent HE Recurrence in a Phase 2B Multi-Center Trial of Veterans With Cirrhosis
-
CLINICAL_TRIALS study record update · 2026-04-09Apixaban Plus Carvedilol to Prevent Portal Hypertension Complications in Cirrhosis: A Randomized Single-Blind Placebo-Controlled Trial at AIMS, Hyderabad, Pakistan
-
CLINICAL_TRIALS study record update · 2026-04-08Randomized Clinical Trial in Hepatic Encephalopathy to Study Lasting Cognitive Improvement With Intravenous Albumin
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-18Safety and Efficacy of Lemborexant for Patients With Cirrhosis and Sleep Problems: a Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2026-03-10A Phase 2b, Double-Blind, Three Arm, Randomized, Placebo Controlled Trial With Restricted Response Adaptive Randomization Testing the Efficacy and Safety of High Dose Methylprednisolone or Equine Anti-Thymocyte Globulin as Treatment for Acute Liver Failure in Pediatric Patients
-
CLINICAL_TRIALS study record update · 2026-03-06A Clinical Randomized Controlled Study on the Prevention and Treatment of Drug-refractory Hepatic Encephalopathy After TIPS With Fecal Microbiota Transplantation
-
CLINICAL_TRIALS study record update · 2026-02-27Clinical Efficacy and Survival Prediction Analysis of Transjugular Intrahepatic Portosystemic Shunt in Patients With Liver Cirrhosis
-
CLINICAL_TRIALS study record update · 2026-02-18Development and Psychometric Validation of The Liver Cirrhosis Cognitive Decline Scale (LiCCoS)
-
CLINICAL_TRIALS study record update · 2026-01-30Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
-
CLINICAL_TRIALS study record update · 2026-01-12A Phase 2, Randomized, Controlled, Open-Label, Adaptive Dose Design, Proof-of-Concept Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Two Different Dwell Times of VS-01 on Top of Standard of Care Versus Standard of Care Alone in Patients With Overt Hepatic Encephalopathy
-
CLINICAL_TRIALS study record update · 2025-12-31Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy
-
CLINICAL_TRIALS study record update · 2025-11-25Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy
-
CLINICAL_TRIALS study record update · 2025-09-25VICIS - Vienna Cirrhosis Study
-
CLINICAL_TRIALS study record update · 2025-09-10A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis
-
CLINICAL_TRIALS study record update · 2025-09-02Efficacy and Safety of Nifuroxazide in the Treatment of Hepatic Encephalopathy in Egyptian Patients With Liver Cirrhosis
-
CLINICAL_TRIALS study record update · 2025-08-28Effect of Supplemental Nightly Melatonin On REM and Cognition in Hepatic Encephalopathy (SNORE-HE) Trial
-
CLINICAL_TRIALS study record update · 2025-07-24Mechanism of Perioperative Systemic Inflammation-Induced Postoperative Neurocognitive Disorders in Chronic Liver Disease Patients Via Blood-Brain Barrier Disruption
-
CLINICAL_TRIALS study record update · 2025-07-24A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis
-
CLINICAL_TRIALS study record update · 2025-07-23A Randomized Open-label Trial of Deprescribing Proton Pump Inhibitors to Reduce the Risk of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Creation
-
CLINICAL_TRIALS study record update · 2025-06-10Branch Chain Amino Acids vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of Hepatic Encephalopathy: Double-blind Placebo-controlled Multicentric Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-06-08Intravenous Branched-chain Amino Acids for Overt Hepatic Encephalopathy in Patients With Acute on Chronic Liver Failure - A Multi-centric Double-blind Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-05-25Fecal Microbiota Transplant in Veterans With Cirrhosis
-
CLINICAL_TRIALS study record update · 2025-05-01Correlation Between Serum Albumin Level and Severity of Hepatic Encephalopathy in Patients With Chronic Liver Disease in Sohag University Hospital